Financhill
Back

Kodiak Sciences Quote, Financials, Valuation and Earnings

Sell
47

KOD
Kodiak Sciences

Last Price:
3.74
Seasonality Move:
14.22%

7 Day Trial

ALL ACCESS PASS

$ 7

Kodiak Sciences Price Quote

$3.74

Kodiak Sciences Key Stats

Sell
47
Kodiak Sciences (KOD) is a Sell

Day range:
$3.72 - $4.03
52-week range:
$1.37 - $9.80
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.74%

Volume:
347.9K
Avg. volume:
438.2K
1-year change:
-29.03%
Market cap:
$196.5M
Revenue:
$0
EPS:
$-4.96

How Much Does Kodiak Sciences Make?

Data Unavailable

Is Kodiak Sciences Growing As A Company?

Data Unavailable

Kodiak Sciences Stock Price Performance

  • Did Kodiak Sciences Stock Go Up Last Month?
    Kodiak Sciences share price went down by -3.36% last month
  • Did KOD's Share Price Rise Over The Last Year?
    KOD share price fell by -29.03% over the past 1 year

What Is Kodiak Sciences 52-Week High & Low?

Kodiak Sciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Kodiak Sciences?

  • How Much Debt Does Kodiak Sciences Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Kodiak Sciences Have?
    Cash and short term investments quarterly total is $285.5M
  • What Is Kodiak Sciences’s Book Value Per Share?
    Book value per share is 5.06

Is Kodiak Sciences Cash Flow Positive?

  • What Is KOD Cash Flow From Operations?
    Cash flow from operations (TTM) is -$154.2M
  • What Is Kodiak Sciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $31K
  • What Is Kodiak Sciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $249.2M

Kodiak Sciences Return On Invested Capital

Data Unavailable

Kodiak Sciences Earnings Date & Stock Price

Kodiak Sciences Competitors

  • Who Are Kodiak Sciences's Competitors?
    Below is a list of companies who compete with Kodiak Sciences or are related in some way:
    • Avalo Therapeutics Inc (AVTX)
    • Dare Bioscience Inc (DARE)
    • iBio Inc (IBIO)
    • Regeneron Pharmaceuticals Inc (REGN)
    • Zevra Therapeutics Inc (ZVRA)

Kodiak Sciences Dividend Yield

Data Unavailable

Kodiak Sciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -50.18%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 4.25
Upside from Last Price: 13.64%

Major Shareholders

  • How many KOD shares are owned by institutional investors?
    47.8M KOD shares are owned by institutional investors
  • How many KOD shares are owned by insiders?
    3.9M KOD shares are owned by insiders